Since the genome of herpes simplex virus 1 (HSV-1) was first sequenced more than 30 years ago, its predicted 80 genes have been intensively studied. Here, we unravel the complete viral transcriptome and translatome during lytic infection with base-pair resolution by computational integration of multi-omics data. We identified a total of 201 viral transcripts and 284 open reading frames (ORFs) including all known and 46 novel large ORFs. Multiple transcript isoforms expressed from individual gene loci explain translation of the vast majority of novel viral ORFs as well as N-terminal extensions (NTEs) and truncations thereof. We show that key viral regulators and structural proteins possess NTEs, which initiate from noncanonical start codons and govern subcellular protein localization and packaging. We validated a novel non-canonical large spliced ORF in the ICP0 locus and identified a 93 aa ORF overlapping ICP34.5 that is thus also deleted in the FDA-approved oncolytic virus Imlygic. Finally, we extend the current nomenclature to include all novel viral gene products.
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Herpes simplex virus 1 (HSV-1) is the causative agent of the common cold sores but also responsible for severe, life-threatening disease including generalized skin infections, pneumonia, hepatitis and encephalitis 1 . The HSV-1 genome is about 152kb in size and known to encode at least 80 open reading frames (ORFs), many of which have been extensively studied. Large-scale RNA-seq and ribosome profiling recently revealed that the coding capacity of three other herpesviruses, namely human cytomegalovirus (HCMV),
Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr Virus (EBV) is significantly larger than previously thought [2] [3] [4] [5] . For HCMV and KSHV, in particular, hundreds
of new viral gene products were identified. These result from extensively regulated usage of alternative transcription and translation start sites throughout lytic infection. Moreover, these viruses were found to encode hundreds of short ORFs (sORFs) of unknown function. Similar to their cellular counterparts, these may either regulate translation of viral gene products or encode for functional viral polypeptides [6] [7] [8] . To date, the majority of novel viral gene products have not been experimentally validated. Furthermore, the lack of a complete annotation and a revised nomenclature severely hampers functional studies.
Overview on the applied functional genomics approaches
Here, we employed a broad spectrum of unbiased functional genomics approaches and reanalyzed recently published data to comprehensively characterize HSV-1 gene products ( Fig. 1 ). Our analyses of the viral transcriptome includes time-course experiments of (i) total RNA-seq and 4sU-seq data 9 , (ii) transcription start site (TiSS) profiling using two complementary approaches (cRNA-seq 2 and dRNA-seq 10 ), (iii) reanalysis of recently published third-generation sequencing data from the PacBio 11 and MinION 12 platforms, and (iv) RNA localization by RNA-seq of subcellular fractions of both wild-type HSV-1 and the deletion mutant of the key viral RNA export factor ICP27 13 . Analyses of the viral translatome includes (i) standard ribosome profiling as well as translation start site (TaSS) profiling using
(ii) Harringtonine and (iii) Lactimidomycin. Novel viral ORFs were validated using whole-cell quantitative proteomics and reverse genetics. To make the annotation and all the obtained data readily accessible to the research community, we provide an HSV-1 genome browser software (available at http://software.erhard-lab.de and as Supplementary Software).
Thereby, viral gene expression and all data can be visually examined from whole genome to single-nucleotide resolution.
Characterization of the HSV-1 transcriptome
To identify the full complement of viral transcripts, we performed TiSS profiling employing a modified RNA sequencing protocol that is based on circularization of RNA fragments (here termed "cRNA-seq") 2 . It enables quantification of RNA levels as well as identification of 5' transcript ends by generating a strong enrichment (≈18-fold) of fragments that start at the 5'
RNA ends. This identified 155 TiSS that explained the expression of many previously annotated viral coding sequences (CDS). To comprehensively identify and validate putative novel TiSS, we applied a second 5'-end sequencing approach termed "differential RNA-seq"
(dRNA-seq) 10 , which provides a much stronger (≈300-fold) enrichment of TiSS at increased sensitivity. It is based on selective cloning and sequencing of the 5'-ends of cap-protected RNA molecules that are resistant to the 5'-3'-exonuclease Xrn1. The two approaches provided highly consistent data at single nucleotide resolution (Fig. 2a) . Furthermore, we reanalyzed recently published third-generation sequencing data obtained using the MinION 14 and PacBio 11 platforms, which confirmed many of the observed TiSS (Suppl. Fig. 1a ,b).
The 98 viral transcripts recently identified by MinION generally lacked 7-18 nucleotides (nt) at the 5' end for technical limitations of the MinION direct RNA sequencing method (Suppl. Fig.   1b ) 15 . Nevertheless, the adjusted TiSS were highly consistent with cRNA-seq and dRNA-seq data ( Fig. 2b) . Around half of all TiSS previously identified using PacBio sequencing 11 matched to our data with single nucleotide resolution, the remaining TiSS (104 of 204; 51%) could neither be confirmed by cRNA-seq, dRNA-seq or MinION (Fig. 2c) . Most of them were only called from very few reads and presumably represent cleavage products of larger viral
RNAs. In total, 113 TiSS were identified by at least two of the four approaches. This demonstrates that complementary experiments are essential to exclude false positives and that none of the approaches by themselves is sufficient to reliably identify all viral TiSS.
To comprehensively assess the viral TiSS candidates that were only identified by a single approach, we developed a computational approach termed iTiSS (integrative Transcriptional Start Site caller). It screens putative TiSS candidates deduced from the cRNA-seq, dRNAseq data, PacBio and MinION data and scores for differences and temporal changes in read coverage upstream and downstream of a TiSS during the course of HSV-1 infection. In addition, iTiSS considered transcripts, which were required to explain translation of novel viral ORFs. A single TiSS could thus score up to a total of 9 points. All identified TiSS were manually assessed and curated. In total, this resulted in 189 viral TiSS of which 159 (84%)
were called by at least 2 criteria (Fig. 2d) . They are also prevalent for herpesvirus genes 20 . The presence of a TATA-box or TATA-box-like motif upstream of the viral TiSS strongly correlated with the expression levels of the respective transcripts. For weakly transcribed viral RNAs, the respective motifs were rarely observed (p<10 -6 , Fisher's exact test). In mammalian cells, the TiSS is marked by the initiator element (Inr), core of which is a pyrimidine-purine (PyPu) dinucleotide 21 .
Interestingly, PyPu was also prevalent for the viral TiSS independent of expression levels (Fig. 2e ). This provides strong evidence for the TiSS of even the most weakly expressed viral transcripts.
We next looked at splicing within the HSV-1 transcriptome based on our total RNA-seq and 4sU-seq data 9 . This confirmed all 8 well-described splicing events and identified 2 additional tandem acceptor sites ("NAGNAG") 22 for the third exon of the ICP0 gene (RL2), as well as for the UL36.6 gene. Recently, Tombácz et al proposed 11 novel splicing events based on PacBio sequencing data 11 . Our data confirmed all of these splicing events. However, only 4
of them occurred at relevant levels (Suppl. Fig. 3 and Suppl. Tab. 2). Two of these explained translation of novel small ORFs (UL40.5 iORF and UL40.7 dORF). Finally, we identified 58 novel putative splicing event sites based on our RNA-seq data (Suppl. Fig. 2 and Suppl. Tab.
2). However, all of these showed substantially lower read coverage than the surrounding exons, indicating that they only represented rare events at best. Therefore, we decided not to include all low abundance splicing events from our new reference annotation. In total, we identified 189 viral TiSS giving rise to at least 201 transcripts and transcript isoforms.
RNA 3'-end processing and export of viral transcripts
Previous studies reported regulated usage of the 47 viral poly(A) sites during productive infection, which appeared to be mediated or at least influenced by the viral ICP27 protein [23] [24] [25] [26] [27] [28] . We recently reported that lytic HSV-1 infection results in a widespread but nevertheless selective disruption of transcription termination of host genes 9 . In contrast to the extensive read-through transcription at host poly(A) sites that we observed by 4-8 h p.i., viral gene expression remained mostly unaffected. Recently published third-generation sequencing data proposed numerous very large viral transcripts spanning multiple viral genes 29 .
To address the nature of these transcripts and their role in translation, we performed RNA-seq on subcellular RNA fractions (total RNA, cytoplasmic RNA, nucleoplasmic RNA and chromatin-associated RNA) using both wild-type HSV-1 30 and a null mutant of the viral RNA export factor ICP27 (ΔICP27). Consistent with the well-characterized role of ICP27 in viral mRNA export 13 , all viral transcripts were more efficiently (≈11-fold) exported to the cytoplasm in wild-type than in Δ ICP27 HSV-1 infection (Fig. 2f) Fig. 3b ).
Furthermore, transcription of UL25, which initiates 107 nt upstream of the UL24 PAS, efficiently bypassed the UL24 PAS already from 2 h p.i. on (Suppl. Fig. 3 ). The same was observed for UL24.5 which represents an N-terminal truncated isoform of UL24. These data confirm previous findings on differential polyadenylation of selective viral genes during productive infection [23] [24] [25] [26] [27] .
HSV-1 expresses hundreds of novel ORFs and sORFs
To comprehensively identify the viral translatome, we performed time-course analysis of ribosome profiling as well as translation start site (TaSS) profiling (see Fig. 1 (Fig. 4a,b) .
We observed seven NTTs originating from downstream translation initiation events of previously described viral coding sequences (Suppl. Tab. 4). All of these initiated with AUG start codons (Fig. 4c) . Alternative TiSS downstream of the main TiSS explained translation of 6 of 7 NTTs (Suppl. Fig. 4 ). Only for US3.5, we could not identify a corresponding transcript.
It thus remains unclear whether US3.5 is translated from an independent transcript or due to leaky scanning. Six of these NTTs (UL8.5, UL12.5, UL24.5, UL26.5, US1.5 and US3. 4d ). This included key viral proteins like the major immediate early protein ICP27, the major capsid protein (VP5, UL19) and the well-studied viral kinase US3. For 5 viral genes, we generated mutant viruses by introducing a triple-FLAG-tag either into the NTE or downstream of the canonical AUG start codon. This confirmed the expression of 6 NTEs including the 2 UL50 NTEs (Fig. 5a-e) . Interestingly, the introduction of a triple-FLAG-tag into the N-terminal extension of both ICP27 and VP5 resulted in dead viruses, which could only be reconstituted upon co-transfection of the mutant bacterial artificial chromosomes (BACs)
with the wild-type virus BAC. For ICP27, expression of the NTE was already observable when the FLAG-tag was introduced downstream of the canonical AUG-start codon (Fig. 5e ).
For VP5, the FLAG-tagged NTE appeared to even be dominant negative. Virus reconstitution upon co-transfection with the wild-type HSV-1 BAC resulted in a partial deletion of the NTE within two passages. This indicates that the FLAG-tagged NTE-MCP is assembled into virus particles but renders them dysfunctional due to the N-terminally inserted triple-FLAG-tag.
To test the impact of the respective NTEs on protein localization, we performed immunofluorescence microscopy of both the NTE-and AUG-tagged viruses. While subcellular localization of the NTEs of ICP27 (UL54) and US5 were indistinguishable from their canonical counterparts (Suppl. Fig. 5 ), the NTEs of US3 and UL50 notably altered subcellular localization (Fig. 5f,g ). While canonical US3 was predominantly nuclear, the NTE-US3 localized to the cytoplasm. The US3 NTE contains a leucine-rich stretch indicating a functional nuclear export signal. Pseudorabies virus (PRV), a porcine alphaherpesvirus, expresses two isoforms of US3, both of which initiate from AUG start codons on separate transcripts (Suppl. Fig. 6 ). The longer isoform encodes a mitochondrial localization signal resulting in the cytoplasmic localization and a failure of the respective protein to be incorporated into the tegument 39 . The DNA sequence of the US3 NTE is conserved in HSV-2 and its role as a nuclear export signal fits data demonstrating that HSV-2 US3 fails to accumulate in the cytoplasm when nuclear export is inhibited 40 . Similar to US3, localization of NTE-UL50 also shifted to the cytoplasm (Fig. 5g ). UL50 dUTPase activity in PRV-infected cells was reported to be nuclear 41 , while it appears to be predominantly cytoplasmic with HSV-2 42 and nearly equally distributed in HSV-1. We conclude that NTEs initiating from non-AUG start codons are common in alphaherpesvirus proteomes. They allow the expression of alternative protein isoforms with different subcellular localization and regulatory motifs.
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In 2015, the first oncolytic virus (talimogene laherparepvec (Imlygic)) was approved for therapy of melanoma 43 . This modified herpes simplex virus 1 lacks two viral genes (ICP34.5
and ICP47) and expresses GM-CSF to recruit and stimulate antigen-presenting cells. Within the ICP34.5 (RL1) locus, we found a novel 93 aa ORF, which we termed RL1A (Fig. 6a ). It initiates from an AUG start codon 46 nt upstream of the AUG start codon of RL1 and is translated from the same transcript at >4-fold higher levels. Imlygic thus lacks a third viral protein, namely RL1A.
A second interesting novel ORF is expressed in the RL2 locus, which encodes the major viral immediate early protein ICP0. Here, we identified a novel spliced ORF (termed RL2A) of 181 aa that initiates from an ACG start codon 116 nt upstream of the ICP0 TaSS (Fig. 6b ).
Expression of RL2A was confirmed by generating a mutant virus with a triple-FLAG-tag inserted 12 nt downstream of the ACG start codon (Fig. 6c) . Interestingly, RL2A expression by the mutant virus could only be detected immediately upon virus reconstitution and was readily lost upon serial passaging indicating that insertion of the triple-FLAG-tag into the RL2A repeat region severely impaired viral fitness.
Transcription of all viral genes continuously increases throughout lytic infection with the exception of the transcript encoding ORF-O and ORF-P. These two partially overlapping
ORFs are expressed antisense to the ICP34.5 (RL1) gene 44 . Consistent with the previous report, the respective transcript was already well detectable in 4sU-seq data at 1 h p.i. but transcriptional activity declined rapidly afterwards (Suppl. Fig. 7a ). Nevertheless, translation of the respective transcripts remained detectable until late times of infection. Interestingly, the absence of a canonical start codon resulted in the hypothesis that ORF-O initiates from the same AUG start codon as ORF-P but then diverges within the first 35 codons due to a ribosomal frame shift. We did not observe any evidence for frame-shifts in the HSV-1 translatome. While translation of ORF-O was only rather weak, our data indicate that it rather initiates from a non-canonical ACG start codon 76 nt upstream of the ORF-P (Suppl. Fig. 7b ).
Finally, we also aimed to validate novel HSV-1 ORFs by whole proteome mass spectrometry.
We obtained triple-SILAC whole proteome data from HSV-1 infected HFF at 0, 4 and 8 h p.i (n=3). Furthermore, we performed whole proteome mass spectrometry from primary lung fibroblasts infected with HSV-1 for 0, 4, 9 and 15 h. In total, this confirmed only 10 (5.5%) of the 186 novel ORFs and sORFs (Suppl. Tab. 3c; excluding NTEs and NTTs). This rather small fraction is consistent with previous work on novel HCMV ORFs 2 and, presumably, reflects that the majority of viral sORFs are inherently unstable and rapidly degraded upon translation similar to their cellular counterparts. Nevertheless, they may play an important role in regulating translation of the viral ORFs encoded downstream of them. Furthermore, the novel large viral ORFs were expressed at substantially lower (~10x) levels than the previously identified viral protein coding sequences (Suppl. Fig. 8 ).
Development of a new integrative nomenclature of HSV-1 gene products
The large number of novel viral gene products required the extension of the current nomenclature. We annotated the novel viral gene products and compiled viral gene units comprising transcript isoforms, ORFs and regulatory entities, e.g. uORFs and uoORFs (Suppl. Tab. 3a). A detailed description of the applied rules is provided in Suppl. Methods. In brief, we fully maintained the current nomenclature for all ORFs in the reference annotation 1 and attributed each ORF to the most highly expressed transcript in its vicinity. Alternative transcript isoforms initiating within less than 500 nucleotides were labeled with "*" (extended)
or "#" (truncated), e.g. UL13 mRNA *1. Finally, alternatively spliced transcripts were labeled with "iso 1" and "iso 2". Short ORFs (<100aa), were named upstream ORF (uORF), upstream overlapping ORF (uoORF), internal ORF (iORF) and downstream ORF (dORF) in relation to the next neighboring large ORF. Any ORF for which no transcript could be identified to be responsible for its translation was labeled as "orphan". An overview of the status of the various kinds of ORFs we identified is shown in Fig. 6d . In accordance, any transcript, which was not found to encode an ORF or sORF within its first 500 nt was also labeled as "orphan".
Interestingly, we identified 41 "orphan" transcripts (Suppl. Tab. 6), which showed predominantly nuclear localization indicating that they may represent novel viral nuclear long non-coding RNAs (lncRNAs). However, all of them were expressed at rather low levels.
Accordingly, we were unable to validate five of them by Northern blots despite extensive efforts. We conclude that HSV-1 does not express any highly transcribed viral non-coding RNAs during lytic infection.
Discussion
In recent years, major advances in high-throughput experimental methodology have revealed that herpesvirus gene expression is surprisingly complex. While a number of studies in the last few years described hundreds of novel viral transcripts and ORFs, a systematic analysis, validation and integration into gene modules, which attribute individual ORFs and sORFs to specific transcripts they are expressed from, was not attempted. Moreover, the lack of a standardized nomenclature has hampered functional studies on these new viral gene products. Based on a wide spectrum of new and published functional genomics data, we here provide a state-of-the-art, fully revised annotation of the HSV-1 genome.
Calling novel gene products based on big data poses the risk of false positives. HFF were utilized from passage 11 to 17 for all high-throughput experiments. Virus stocks for wild-type HSV-1 were produced on baby hamster kidney (BHK) cells as described. Stocks of the ICP27 null mutant (strain KOS) 49 were produced on complementing Vero 2-2 cells 50 .
HFF were infected for 15 min at 37°C about 24 h after the last split using a multiplicity of infection (MOI) of 10. Subsequently, the inoculum was removed and fresh media was applied to the cells.
To reconstitute the FLAG-tagged UL19 NTE, BHK-21 dox-UL19 cells with doxycyclineinducible expression of UL19 were generated by cloning the HSV-1 Syn17+ UL19 coding sequence using primers described in Suppl. Tab. 7 into the SalI and NheI sites of pTH3, a derivative of pCW57.1 with a custom multiple cloning site in lieu of the gateway cloning site and the addition of the TRE tight promoter from pTRE-Tight. Lentiviral vectors were generated by cotransfection of this construct with psPAX2 and pCMV-VSV-G into 293T cells.
Lentivirus-containing supernatants were sterile-filtered with Minisart® NML 0.45µm cellulose acetate filters (Sartorius #17598) and added to BHK-21 cells. Polyclonal populations were selected 48 h post-transduction and maintained in 1µg/mL puromycin.
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Viral mutagenesis and reconstitution
All viral mutants were generated via en passant mutagenesis 51 using Escherichia coli strain GS1783 with the bacterial artificial chromosome (BAC) HSV1(17+)-LoxCheVP26 52 expressing a fusion protein of mCherry on the N-terminus of the UL35 gene product (VP26).
Full primer and construct sequences can be found in the Suppl. Tab. 7. BAC DNA was purified using the NucleoBond BAC 100 kit (Macherey-Nagel #740579) and transfected for virus reconstitution into BHK-21 cells with Lipofectamine 3000 (ThermoFisher #L3000-075).
HSV-1 expressing the FLAG-tagged N-terminal extension of UL54 virus were reconstituted and titrated on Vero 2-2 cells 50 . The virus expressing the tagged N-terminal extension of UL19 was generated in BHK-21 dox-UL19 cells. BHK-21 dox-UL19 cells were plated the day before in media containing 1µg/mL doxycycline (Sigma #D3072), which was maintained throughout virus generation.
Virus produced by transfected cells was expanded on minimally five T175 flasks of the corresponding cell type. Virus-containing supernatants were harvested upon >90% cytopathic effect and centrifugation at 8,000 RCF at 4°C for 10 min to pellet cells. Cell pellets were snap-frozen in liquid nitrogen and thawed at 37°C three times to free cell-associated virus. Cellular debris was pelleted at 10,000 RCF, 4°C for 10 min and supernatant combined with the supernatant in the previous step. Virions were pelleted by centrifugation at 19,000 RCF for two hours at 4°C, resuspended in phosphate-buffed saline (PBS), and pelleted once more over a 20% (w/v) sucrose cushion in PBS 16,000 RPM for two hours at 4°C in a SW 28 swinging-bucket rotor (Beckman). Virus pellets were resuspended in PBS, snap-frozen in liquid nitrogen, stored at -80°C, and titrated by plaque assay. Infections were carried out in serum-free DMEM containing penicillin and streptomycin for 1 h at 37°C. The time at which inoculum was replaced with growth media was marked as the 0 h timepoint.
Western blot
Samples were harvested at the indicated timepoints by removal of growth media and direct lysis in 2x Laemmli buffer containing 5% (v/v) β-mercaptoethanol. Samples were sonicated and heated for 5 min at 95°C before loading onto a Novex™ WedgeWell™ 4-20% TrisGlycine Gel (ThermoFisher #XP04200BOX). Proteins were transferred to polyvinylidene difluoride (PVDF) membranes, blocked for 1 h at room temperature in 1xPBST containing 5% (w/v) milk (Carl Roth T145.3), and probed using α-FLAG M2 (Sigma #F1804) overnight at 4°C at a 1:1000 at dilution and α-mouse IgG (whole molecule)-peroxidase (Sigma #9044) for 1 h. β-actin was probed using α-β-actin C4 antibody (Santa Cruz #sc-47778) at a 1:1000 dilution for 1 h, followed by IRDye® 800CW goat α-mouse IgG (LI-COR #926-32210) at 1:5000 for 1 h. ICP0 was probed using α-ICP0 clone 5H7 (Santa Cruz #sc-56985) at a 1 3 
2.2]octane (DABCO).
Transcription start site (TiSS) profiling
Total cellular RNA was isolated using Trizol (Invitrogen) following the manufacturer's instructions. RNA was resuspended in water and stored at -80°C until use. TiSS profiling using cRNA-seq was performed as described for HCMV 2 . TiSS using dRNA-seq was performed according to the published protocol 10 and 7+ were isolated for fragmentation in top speed mode using the quadrupole with a 1.6 m/z isolation window. HCD fragmentation was performed at 33% collision energy with 1 6
fragments detected in the ion trap between 350-1400 m/z. AGC was set to 5 × 10 3 and MS2 spectra were acquired in centroid mode.
Data analysis, statistics and reproducibility
Random and sample barcodes in cRNA-seq and ribosome profiling data were analyzed as described 9 . Briefly, barcodes and 3' adapters were trimmed from the reads using our inhouse computational genomics framework gedi (available at https://github.com/erhardlab/gedi). Reads were mapped using bowtie 1.0 against the human genome (hg19), the human transcriptome (Ensembl 75) and HSV-1 (JN555585). All alignments for a read with minimal number of mismatches were filtered and assigned to specific samples based on the sample barcode. PCR duplicates were collapsed based on random barcodes while paying attention to sequencing errors.
dRNA-seq data was processed in a similar manner to the cRNA-seq and ribosome profiling data with the exception that PCR duplicates were not collapsed as no random barcodes were used. 4sU-seq, total RNA-seq and RNA-seq data of subcellular fractions were analyzed as 
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The reported enrichment factors for dRNA-seq and cRNA-seq were calculated based on predicted TiSS in human rather than HSV-1. This was done to prevent undesired biases due to read-in caused by the extraordinary high number of overlapping transcripts in HSV-1. The predicted TiSS were ordered based on the number of reads starting at their respective positions. The median was then calculated over the 50 strongest and 10 strongest expressed TiSS for cRNA-seq and dRNA-seq, respectively.
Significance of the correlation between the presence of a TATA-box-like motif and the transcription strength of TiSS was calculated using Fisher's exact test. Here, the TiSS were ordered by their numbers of reads starting and sorted into three equally sized bins. For the bin containing the strongest TiSS as well as the bin containing the weakest TiSS, the number of all nucleotides between position -30 and -25 relative to the TiSS were summed up. For the parameters of the Fisher's exact test, the following sums were used a=T+A(strongest bin), b=C+G(strongest bin), c=T+A(weakest bin) and d=C+G(weakest bin).
We used our in-house tool PRICE 5 version 1.0.1 to call ORFs separately for the two replicates of ribosome profiling data but pooling all samples from each replicate.
RNA-seq data were mapped using STAR 58 version 2.5.3a using a combined reference index derived from Ensembl 90 and our final HSV-1 annotation.
We analyzed mass spectrometry data using MaxQuant 59 version 1.6.5.0. Spectra were matched against a combined database of proteins from Ensembl (version 75), and all ORFs identified by ribosome profiling. We used carbamidomethylation as fixed and acetylation (Nterminal) and oxidation at methionine as variable modifications. Peptides were filtered for 1%
FDR using the target-decoy approach by MaxQuant.
The export indices of chromatin-associated RNA and cytoplasmic RNA were derived by computing their fold changes between the wild type and the null mutant for ICP27 using the lfc R-package 60 .
Analysis of the predicted protein sequences to reveal function and functional motifs used sequence comparison, domain composition, structure prediction and motif searches as described previously [61] [62] [63] .
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article. Tables and analyze the omics data are available at zenodo (doi: 10.5281/zenodo.2621226).
Code availability
Scripts used to create the Figures and
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Data availability
All sequencing data have been deposited in the Gene Expression Omnibus (GEO) database with accession codes GSE128324 (Translation start site profiling, transcription start site profiling), GSE59717 (4sU-seq and total RNA-seq), GSE60040 (ribosome profiling) and GSE128880 (cytoplasmic, nucleoplasmic and chromatin-associated RNA). Additional data from other sources utilized in this work are available at the GEO database with accession code GSE97785 (PacBio) 11 , and from the European Nucleotide Archive (ENA) with the study accession code PRJEB27861 (MinION) 12 . The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifiers PXD013010 and PXD013407. . Furthermore, screening our RNA-seq and 4sU-seq data for novel splicing events with at least 10 nt exonspanning reads identified 58 putative additional splicing events. However, exon-spanning reads were >10-fold less prevalent than reads mapping to the flanking regions. We therefore, decided not to include them into our new reference annotation. Nevertheless, the may explain some of the "orphan" ORFs. Our data confirmed all 11 splicing events. However, only four of them occurred at relevant levels and were included into our new reference annotation. All newly identified ORFs show lower expressions than the previously identified ones (CDS).
Supplementary
Most of the novel large ORFs are expressed at relatively low levels compared to the known large viral ORFs. 
